Literature DB >> 1065903

Interactions between nutritional factors and drug biotransformations in man.

A P Alvares, K E Anderson, A H Conney, A Kappas.   

Abstract

This study was undertaken to examine the influence of nutritional factors on the activity of the mixed function oxidase system in man, which is cytochrome P-450 dependent. Three normal volunteers were fed a low carbohydrate-high protein diet for 2 weeks, followed by a high carbohydrate-low protein diet for the follwoing 2 weeks. At the end of each test diet period, the plasma elimination rates of antipyrine and theophylline were determined. The mean plasma half-life for antipyrine was 17.5 hr on the high carbohydrate-low protein diet and 9.2 hr on the low carbohydrate-high protein diet. The mean plasma half-life for theophylline was 8.9 hr on the high carbohydrate-low protein diet and 5.9 hr on the low carbohydrate-high protein diet. These data demonstrate marked influences of dietary carbohydrate and/or protein ingestion on oxidative biotransformation of drugs in man.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1065903      PMCID: PMC430624          DOI: 10.1073/pnas.73.7.2501

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  FACTORS AFFECTING THE EXCRETION OF PORPHYRIN PRECURSORS BY PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA. I. THE EFFECT OF DIET.

Authors:  F H WELLAND; E S HELLMAN; E M GADDIS; G COLLINS; G W HUNTER; D P TSCHUDY
Journal:  Metabolism       Date:  1964-03       Impact factor: 8.694

2.  Effect of diet on induction of experimental porphyria.

Authors:  J A ROSE; E S HELLMAN; D P TSCHUDY
Journal:  Metabolism       Date:  1961-07       Impact factor: 8.694

3.  Comparative theophylline blood levels following the oral administration of three different theophylline preparations.

Authors:  J SCHLUGER; J T MCGINN; D J HENNESSY
Journal:  Am J Med Sci       Date:  1957-03       Impact factor: 2.378

4.  An ultraviolet spectrophotometric method for the determination of theophylline and theobromine in blood and tissues.

Authors:  J A SCHACK; S H WAXLER
Journal:  J Pharmacol Exp Ther       Date:  1949-11       Impact factor: 4.030

5.  The fate of antipyrine in man.

Authors:  B B BRODIE; J AXELROD
Journal:  J Pharmacol Exp Ther       Date:  1950-01       Impact factor: 4.030

6.  Toxicity and metabolism of drugs in relation to dietary protein.

Authors:  R Kato; T Oshima; S Tomizawa
Journal:  Jpn J Pharmacol       Date:  1968-09

7.  Genetic control of drug levels and of the induction of drug-metabolizing enzymes in man: individual variability in the extent of allopurinol and nortriptyline inhibition of drug metabolism.

Authors:  E S Vesell; G T Passananti; F E Greene; J G Page
Journal:  Ann N Y Acad Sci       Date:  1971-07-06       Impact factor: 5.691

Review 8.  Studies on the mechanism of carbohydrate repression in rat liver.

Authors:  C Peraino; C Lamar; H C Pitot
Journal:  Adv Enzyme Regul       Date:  1966

9.  Metabolic interactions among environmental chemicals and drugs.

Authors:  A H Conney; J J Burns
Journal:  Science       Date:  1972-11-10       Impact factor: 47.728

Review 10.  Role of nutrition in the drug-metabolizing enzyme system.

Authors:  T C Campbell; J R Hayes
Journal:  Pharmacol Rev       Date:  1974-09       Impact factor: 25.468

View more
  25 in total

Review 1.  Research review. Interactions between environmental chemicals and drug biotransformation in man.

Authors:  A P Alvares
Journal:  Clin Pharmacokinet       Date:  1978 Nov-Dec       Impact factor: 6.447

2.  Reduced methylprednisolone clearance causing prolonged pharmacodynamics in a healthy subject was not associated with CYP3A5*3 allele or a change in diet composition.

Authors:  Su-Jun Lee; William J Jusko; Christine G Salaita; Karim A Calis; Michael W Jann; Vicky E Spratlin; Joyce A Goldstein; Yuen Yi Hon
Journal:  J Clin Pharmacol       Date:  2006-05       Impact factor: 3.126

3.  Racial differences in drug responses--a comparative study of trimazosin and alpha 1-adrenoceptor responses in normotensive Caucasians and West Africans.

Authors:  J Vincent; H L Elliott; P A Meredith; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1986-04       Impact factor: 4.335

Review 4.  Drug metabolism and pharmacokinetics in malutrition.

Authors:  K Krishnaswamy
Journal:  Clin Pharmacokinet       Date:  1978 May-Jun       Impact factor: 6.447

5.  Effect of surgery under general anaesthesia on antipyrine clearance.

Authors:  D Pessayre; H Allemand; C Benoist; F Afifi; M François; J P Benhamou
Journal:  Br J Clin Pharmacol       Date:  1978-12       Impact factor: 4.335

6.  Antipyrine metabolism in cancer patients.

Authors:  T Higuchi; T Nakamura; H Uchino
Journal:  Experientia       Date:  1980-02-15

7.  Dose dependence of the 14C-aminopyrine breath test. Intrasubject comparison of tracer and pharmacological doses.

Authors:  I Gikalov; J Bircher
Journal:  Eur J Clin Pharmacol       Date:  1977-11-14       Impact factor: 2.953

8.  Dietary influences on the kinetics of antipyrine and aminopyrine in human subjects.

Authors:  K Krishnaswamy; R Kalamegham; N A Naidu
Journal:  Br J Clin Pharmacol       Date:  1984-02       Impact factor: 4.335

Review 9.  Influence of diet and nutritional status on drug metabolism.

Authors:  I Walter-Sack; U Klotz
Journal:  Clin Pharmacokinet       Date:  1996-07       Impact factor: 6.447

10.  Chemotherapy of larval echinococcosis with mebendazole: microsomal liver function and cholestasis as determinants of plasma drug level.

Authors:  F Witassek; J Bircher
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.